Peter Feinberg has served on the Notable Board of Directors since 2023. Since April 2020, Feinberg has been a founder of Sporos Bioventures, Inc., a private biotechnology company focused on transforming the drug development process across oncology.
Since June 2019, Feinberg has served as partner and founding member of Boxcar Partners and Boxcar PMJ LP, a venture capital investment firm with a focus on biotechnology investing. Since October 2018, he has also been the co-founder of Emerging Security Solutions. Feinberg is the co-founder of BridgeBio Pharma, Inc. (Nasdaq: BBIO), a publicly traded biotechnology company focusing on genetic diseases, which he helped found in 2014. Previously, Feinberg served as a managing director and head of institutional equities trading at Oppenheimer & Co, with his tenure ranging from July 1982 to December 2015. He has served on the board of directors of Immuneering Corporation (Nasdaq: IMRX), a biotechnology company that aims to apply bioinformatics to create a new approach to drug discovery, since 2021.
Feinberg earned a bachelor of science degree in finance from Whittier College, Whittier, Calif.
